247 hasil
Menampilkan 1–20 · 0,35 detik · RSS
Journal of Bone Marrow Transplantation and Cellular Therapy
ISSN 2675-374X · Sociedade Brasileira de Terapia Celular e Transplante de Medula Óssea · 247 artikel di indeks
-
Artikel Jurnal
CAR-T cells and other cellular therapies for solid tumors: Current challenges and emerging solutions
Recent advances in cancer immunotherapy have transformed adoptive cellular therapy, yielding remarkable clinical outcomes in hematological malignancies, whereas its efficacy in solid tumors remains severely limited by the immunosuppressive tumor microenvironment, antigen heterogeneity, and…
-
Artikel Jurnal
Hematopoietic cell transplantation in pediatric chronic myeloid leukemia
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder primarily linked to the BCR-ABL fusion gene, resulting from the Philadelphia chromosome translocation. While rare in pediatric populations, CML in children presents unique biological and clinical features, often diagnosed…
-
Artikel Jurnal
What does the pharmacist need to know?
Objective: To describe the main knowledge and skills required of pharmacists who work or wish to work in chimeric antigen receptor T cells (CAR-T) cell therapy. Methods: This is a narrative literature review based on international guidelines, clinical trials, and recommendations from specialized…
-
Artikel Jurnal
Gynecological chronic graft-versus-host disease: screening, diagnosis, and treatment. Brazilian Society of Cell Therapy and Bone Marrow Transplantation consensus
Objectives: To provide an updated review of the diagnosis, preventive measures, screening, and treatment of genital involvement in chronic graft-versus-host disease (cGVHD). Methods: A literature review was conducted using the PubMed and Google Scholar databases in January 2026. Results: The review…
-
Artikel Jurnal
Effectiveness of therapeutic drug monitoring in patients undergoing allogeneic hematopoietic stem cell transplantation
Background: Therapeutic drug monitoring (TDM) aims to prevent excessive immunosuppression, graft rejection, and the emergence of graft-versus-host disease (GVHD) and to control drug interactions. Estimates suggest that acute GVHD (aGVHD) occurs in 30-50% of patients undergoing allogeneic…
-
Artikel Jurnal
Current activity trends and outcomes of hematopoietic cell transplantation: A 2026 report from the Brazilian Registry of Hematopoietic Cell Transplantation in collaboration with the CIBMTR & SBTMO
The development of the Brazilian Registry of Hematopoietic Cell Transplantation (Registro Brasileiro de Transplantes de Células Hematopoieticas), in collaboration with the Center for International Blood and Marrow Transplant Research (CIBMTR), continues to provide a comprehensive assessment of…
-
Artikel Jurnal
Global expert perspectives on the future of hematopoietic cell transplantation and cell therapies
Settings: Hematopoietic cell transplantation (HCT) remains a cornerstone therapy for hematologic malignancies and several non-malignant disorders. At the same time, emerging therapies, particularly chimeric antigen receptor T cell (CAR-T) cells and other immunotherapies, are transforming the…
-
Artikel Jurnal
Genetic engineering strategies for cell-based therapy: viral, non-viral, and precision genome editing technologies
Objective: To review the existing genetic engineering strategies commonly used for generating chimeric antigen receptor (CAR)-T cell therapy. Methods: This article provides a comprehensive literature review and compares different approaches on viral, non-viral and precision genome editing…
-
Artikel Jurnal
Lymphocyte collection for cellular therapy
Introduction: Leukapheresis is the starting point of cellular therapies such as chimeric antigen receptor T cells (CAR-T cells) and donor lymphocyte infusion. Methods: After a review of the literature, we provided guidance on how to evaluate candidates for leukapheresis and how to optimize the…
-
Artikel Jurnal
Clonal histiocytosis associated with evolving acute myeloid leukemia: a case report and literature review
Histiocytoses are rare disorders that may occur in association with hematologic malignancies, although reports preceding acute myeloid leukemia (AML), particularly in adults, remain scarce. We report the case of a 58-year old female patient who presented with persistent fever, weight loss, and…
-
Artikel Jurnal
Current use and outcomes of cellular therapy: Brazilian Summary Slides – 2026
Objective: To describe CAR-T cell therapy activity and outcomes reported by Brazilian centers participating in the Brazilian Society of Cellular Therapy and Bone Marrow Transplantation (SBTMO)/Center for International Blood and Marrow Transplant Research (CIBMTR) network between January 2020 and…
-
Artikel Jurnal
Sinusoidal obstruction syndrome
Objectives: To provide an updated version of the Sociedade Brasileira de Terapia Celular e Transplante de Medula Óssea (SBTMO) 2021 consensus on sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD), incorporating recent evidence regarding pathophysiology, risk stratification, diagnosis…
-
Artikel Jurnal
Occupational therapy in hospital playroom for children with Fanconi anemia undergoing hematopoietic stem cell transplantation
Introduction: Pediatric hospitalization is potentially stressful, especially when associated with rare diseases and prolonged treatments, such as Fanconi anemia (FA) and hematopoietic stem cell transplantation, which may impact children’s neuropsychomotor and emotional development by restricting…
-
Artikel Jurnal
Manufacturing of CAR-T cells using in-house vectors and the CliniMACS Prodigy
Objectives: This article provides a practical, regulatory-focused guide for the clinical-grade manufacturing of autologous CAR-T cells using in-house lentiviral vectors and the CliniMACS Prodigy system. Methods: A narrative review and technical synthesis of the scientific literature, institutional…
-
Artikel Jurnal
Beyond HLA matching: a practical framework for selecting among HLA-identical donors in hematopoietic stem cell transplantation
Background: Donor selection in allogeneic hematopoietic stem cell transplantation (HSCT) has evolved beyond human leukocyte antigen (HLA) compatibility. Advances in transplant platforms and immunogenetics have highlighted the importance of integrating additional donor-related clinical and…
-
Artikel Jurnal
Oral pyogenic granulomas: a rare manifestation of oral graft-versus-host-disease
Background: Chronic graft-versus-host disease (cGVHD) is a frequent complication following allogeneic hematopoietic cell transplantation (allo-HCT) and commonly affects the oral cavity. Up to 80% of patients develop oral manifestations, which may significantly impair quality of life, especially in…
-
Artikel Jurnal
Brazilian Guidelines for Ocular Graft-versus-Host Disease After Hematopoietic Stem Cell Transplantation: Recommendations from the Brazilian Society of Bone Marrow Transplantation
Chronic graft-versus-host disease (GVHD) is the most significant long-term complication of allogeneic hematopoietic stem cell transplantation (HSCT), with ocular involvement, predominantly dry eye disease (DED), affecting 40–60% of patients and causing substantial morbidity. This consensus…
-
Artikel Jurnal
Hematopoietic progenitor cell mobilization, collection, transportation, and infusion of fresh products
Introduction: The quality of the graft is a critical determinant of transplant success. Methods: Literature review and expert discussion. Results: In this review, we highlight the essential aspects of hematopoietic progenitor cell mobilization and collection, including apheresis and bone marrow…
-
Artikel Jurnal
Hematopoietic stem cell transplantation in an adult patient with primary hemophagocytic lymphohistiocytosis
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory condition characterized by uncontrolled immune activation and excessive production of pro-inflammatory cytokines, which may rapidly progress to multiorgan failure. Despite efforts to simplify the diagnosis and…
-
Artikel Jurnal
Hematopoietic cell transplantation for myelodysplastic syndromes
For patients with myelodysplastic syndromes (MDS), allogeneic hematopoietic cell transplantation (HCT) is considered the only treatment with curative potential. However, its use is restricted to a selected group of patients, and transplant outcomes are influenced by a complex interaction of disease…